The last time we were down here was 2017... 8 years of company growth obliterated. The difference between then and now is that we have a chair and MD/CEO taking enormous wages expected for a company worth billions, a failed phase 2 completed drug, and more phase 1 programs than we can fund.
The final glaring nail in the coffin here is that even sub 100 million market cap NOT ONE big player is interested in taking it over. They could EASILY get shareholder approval for even a 3c/share takeover bid just to put everyone out of their misery, but crickets.
If you're in distress, there are numbers to call, please seek help and don't do anything silly.
IMU Price at posting:
1.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)